Read More News Here’s Why BIOLASE Shares Were Volatile This Week By Henry Khederian September 15, 9:56 AM BIOLASE Inc (NASDAQ: BIOL) shares are trading lower by 37% to $2.00 over the trailing five sessions after the company this week announced pricin BIOL
Read More Analyst Ratings Initiation News Price Target Credit Suisse Initiates Coverage On Fulgent Genetics with Outperform Rating, Announces Price Target of $65 By Benzinga Newsdesk August 25, 5:35 AM Credit Suisse analyst Dan Leonard initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Outperform rating and announces Price Target of $65. FLGT
Read More Management News Strategic Organizing Center Releases Investor Presentation Highlighting On Why Board Change Is Needed Now In Order To “Brew A Better Starbucks” By Benzinga Newsdesk February 20, 10:24 AM Details why Starbucks' flawed human capital management strategy is the most critical issue facing the Company today and how the Board's failed oversight has cost shareholders, employees and customersBelieves that the SBUX
Read More Economics Macro Economic Events News U.S. To Announce New $400M Military Aid Package For Ukraine On Friday By Happy Mohamed Today, 3:57 PM - U.S. Officials SPY